RJA
KOD icon

Raymond James & Associates’s Kodiak Sciences KOD Stock Holding History

Raymond James & Associates’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,155
Closed -$85K – 4054
2022
Q2 		$85K Sell
11,155
-7,268
-39% -$51.1K ﹤0.01% 3709
2022
Q1 		$142K Sell
18,423
-4,382
-19% -$171K ﹤0.01% 3755
2021
Q4 		$1.93M Sell
22,805
-35
-0.2% -$3.56K ﹤0.01% 2200
2021
Q3 		$2.19M Sell
22,840
-1,868
-8% -$173K ﹤0.01% 2033
2021
Q2 		$2.3M Sell
24,708
-9,456
-28% -$908K ﹤0.01% 1999
2021
Q1 		$3.87M Buy
34,164
+1,235
+4% +$169K ﹤0.01% 1592
2020
Q4 		$4.84M Sell
32,929
-9,620
-23% -$1.07M 0.01% 1364
2020
Q3 		$2.52M Sell
42,549
-557
-1% -$28K ﹤0.01% 1611
2020
Q2 		$2.33M Buy
43,106
+540
+1% +$30.5K ﹤0.01% 1645
2020
Q1 		$2.03M Sell
42,566
-3,833
-8% -$230K ﹤0.01% 1563
2019
Q4 		$3.34M Sell
46,399
-302
-0.6% -$11K ﹤0.01% 1519
2019
Q3 		$672K Buy
+46,701
New +$610K ﹤0.01% 2455

Other funds holding KOD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Raymond James & Associates's KOD Position: Q3 2022 in Review

Raymond James & Associates sold out of Kodiak Sciences (KOD) in Q3 2022, closing a stake of 11,155 shares — an estimated $85K sold.

Raymond James & Associates first reported a position in KOD in Q3 2019 and held it in 12 quarters. The position peaked at $4.84M in Q4 2020. 143 funds tracked by Wall St. Rank hold KOD as of Q3 2022.

  • Raymond James & Associates reported no remaining Kodiak Sciences position as of Q3 2022 after selling out during the quarter.
  • Raymond James & Associates sold 11,155 Kodiak Sciences shares in Q3 2022, an estimated $85K.
  • Raymond James & Associates first reported a position in Kodiak Sciences in Q3 2019 and held it in 12 quarters.
  • Raymond James & Associates's Kodiak Sciences position peaked at $4.84M in Q4 2020.
  • 143 funds tracked by Wall St. Rank held Kodiak Sciences as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.